The healthcare sector encompasses a broad range of businesses and services dedicated to providing medical care, preventive care, and wellness services. It includes hospitals, clinics, and medical practices that offer patient care, as well as public health organisations and entities focused on health promotion and disease prevention.
- Components: The sector includes various subsectors such as healthcare providers, medical equipment manufacturers, pharmaceutical companies, and biotechnology firms.
- Economic impact: The healthcare sector is a significant part of the economy, contributing to employment and technological innovation.
- Services offered: Services range from primary care and specialised medical treatments to emergency care and rehabilitation services.
- Public and private: It consists of both public institutions funded by the government and private entities that operate for profit or as non-profits.
The healthcare sector is critical for maintaining public health and improving quality of life, constantly evolving with advancements in medical research and technology.
What is the healthcare industry?
The healthcare industry is one of the largest sectors in India in terms of both revenue and employment. It includes a wide range of segments such as hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The sector continues to grow steadily, driven by improved access to healthcare services, expanding infrastructure, and rising spending by both government and private players.
India’s healthcare delivery system is broadly divided into two segments: public and private. The public healthcare system, managed by the government, focuses on providing basic healthcare services through Primary Healthcare Centres (PHCs), especially in rural areas, along with a limited number of secondary and tertiary care institutions in urban centres. In contrast, the private sector accounts for a majority of secondary, tertiary, and quaternary care services, with a strong presence in metro cities as well as Tier I and Tier II locations.
A key strength of India’s healthcare sector is its large pool of skilled and well-trained medical professionals. Additionally, India offers significant cost advantages compared to many Asian and Western countries. For instance, surgical procedures in India can cost nearly one-tenth of what they do in the US or Western Europe, making the country a preferred destination for medical tourism and clinical research.
Healthcare industry in India: market size and statistics
The Indian healthcare sector has witnessed rapid expansion over the years. It was valued at Rs. 9,42,590 crore (US$ 110 billion) in 2016 and grew to Rs. 31,87,668 crore (US$ 372 billion) in 2023. It is further expected to reach Rs. 54,67,022 crore (US$ 638 billion) by 2025, reflecting a strong CAGR of 17.5% to 22.5%. Healthcare spending accounted for 3.3% of India’s GDP in 2022 and is projected to increase to 5% by 2030.
| Indicator | Data |
|---|---|
| Hospital market value (2023) | US$ 98.98 billion |
| Projected hospital market value (2032) | US$ 193.59 billion (CAGR of 8.0%) |
| Healthcare sector value (2023) | US$ 372 billion |
| Projected sector value (by 2025) | US$ 638 billion |
| Healthcare spending (% of GDP, 2022) | 3.3% |
| Projected healthcare spending (% of GDP, 2030) | 5% |
| Registered allopathic doctors (as of April 2025) | 13,86,150 |
| Doctor-to-population ratio | 1:811 |
| Medical tourism market value (2024) | US$ 7.69 billion |
| Digital health market (2024) | Rs. 75,658 crore (US$ 8.79 billion) |
| FDI in Drugs & Pharmaceuticals (Apr 2000 to Jun 2025) | US$ 24.62 billion |
Pharmaceuticals, biotechnology and life sciences
India’s pharmaceuticals sector holds a strong global position. The country is the largest supplier of generic medicines worldwide, contributing over 20% of global exports by volume. It also provides more than 60% of the world’s vaccines, making it a critical source of affordable medicines for both domestic use and international markets.
- Pharmaceuticals: India has more than 3,000 pharmaceutical companies and over 10,500 manufacturing units. The sector is expected to grow significantly and reach a value of US$ 130 billion by 2030.
- Biotechnology: India’s biotechnology industry ranks among the top 12 globally. It includes key segments such as biopharmaceuticals, bioservices, bioagriculture, bioindustrials, and bioinformatics.
- Medical devices: The Indian medical devices market is projected to reach US$ 50 billion by 2025, driven by increasing demand for diagnostics, imaging systems, and patient monitoring equipment.
- Life sciences R&D: India has become a preferred destination for global clinical research, supported by a diverse patient base, skilled researchers, and comparatively lower clinical trial costs.
India’s competitive advantage in healthcare
India’s healthcare sector benefits from several structural advantages that make it a strong destination for investment, medical tourism, and global partnerships.
Strong demand
Demand for healthcare services and professionals in India is expected to rise sharply, both domestically and globally, by 2030. By 2025, the country will need nearly three million additional hospital beds to meet the target of three beds per 1,000 population, highlighting the scale of ongoing infrastructure expansion.
Attractive opportunities
Public spending on healthcare in India is expected to reach 1.9% of GDP in FY26. The sector is also witnessing strong investor interest, with private equity investments reaching record levels. In Q1 2025 alone, there were 71 deals valued at Rs. 22,279 crore (US$ 2.6 billion), indicating growing confidence in the sector.
Rising healthcare workforce
India’s healthcare workforce has already crossed 6 million as of CY24. The addition of 157 new medical colleges, along with 74,306 postgraduate seats and 1,18,190 MBBS seats as of April 2025, reflects a rapidly strengthening talent pipeline.
Policy and government support
The government has allocated Rs. 99,858 crore (US$ 11.50 billion) to the healthcare sector in the Union Budget 2025–26. Key initiatives such as Ayushman Bharat – PM-JAY, the Ayushman Bharat Digital Mission (ABDM), and the National Health Mission are expanding healthcare access to hundreds of millions of citizens across the country.
Investing in the healthcare sector
India’s healthcare sector offers strong investment potential across a wide range of segments, driven by rising demand, policy support, and increasing private participation. Key opportunities across segments are outlined below:
| Investment Segment | Key Opportunity | Growth Driver |
|---|---|---|
| Hospitals and diagnostics | Expansion of bed capacity and deeper reach into Tier II and Tier III cities | Rising income levels, expanding middle class, and higher health awareness |
| Pharmaceuticals | Growth in generic drug exports, biosimilars, and specialty pharmaceuticals | Global demand for cost-effective medicines and benefits from India UK FTA duty relief |
| Digital health and telemedicine | Remote patient monitoring and growth of health tech platforms | Market expected to reach US$ 47.80 billion by 2033 with a CAGR of 17.67% |
| Medical devices | Increased demand for diagnostics, imaging, and monitoring equipment | Focus on import substitution and domestic manufacturing initiatives |
| Health insurance | Expansion in coverage and growth of standalone health insurers | Rising premiums of Rs. 1,18,688 crore in FY25 and strong government support |
| Medical tourism | Increasing inflow of international patients and premium treatment services | Market projected to reach US$ 14.31 billion by 2029 |
Government initiatives for India’s healthcare sector
The Government of India has introduced several large-scale initiatives to strengthen healthcare infrastructure, improve accessibility, and support long-term growth:
- Ayushman Bharat – PM-JAY: India’s flagship health insurance scheme, with over 41 crore Ayushman Cards issued, 31,466 empanelled hospitals, and more than 9 crore hospitalisations covered.
- Ayushman Bharat Digital Mission (ABDM): Over 73.98 crore Ayushman Bharat Health Accounts created as of February 2025, with 49.06 crore health records successfully linked.
- Union Budget 2025 to 26 allocation: The healthcare sector received Rs. 99,858 crore (US$ 11.50 billion), with an additional allocation of Rs. 531 crore for the Department of Health Research.
- New medical colleges: 157 new medical colleges are being developed by upgrading district and referral hospitals, with 131 already operational and 22 new AIIMS approved.
- Poshan Abhiyan: A centrally sponsored scheme focused on improving nutrition among women and children to enhance maternal and child health outcomes across states and union territories.
- Universal Immunisation Programme (UIP): Targets 2.6 crore newborns and 2.9 crore pregnant women each year, with significant progress in achieving high immunisation coverage nationwide.
- India UK Free Trade Agreement (2025): Signed on July 24, 2025, this agreement offers duty benefits, enabling Indian pharmaceutical companies to expand exports in the UK market.
- AYUSH promotion: India has signed 25 government level MoUs and 52 institutional MoUs to promote AYUSH globally, with increased budgetary allocation to the Ministry of AYUSH.
Future of India’s healthcare industry: road ahead
India’s healthcare sector is highly diverse and continues to create opportunities across providers, payers, and medical technology. Several key trends are expected to shape its future:
- Advanced diagnostics: India is emerging as a leading destination for high-end diagnostic services, supported by increasing investments in advanced facilities.
- Rising consumer awareness: Consumers are becoming more proactive about healthcare, with higher income levels and awareness driving demand for better services.
- Preventive healthcare: Growing focus on preventive care, supported by wellness apps, wearable devices, and digital health platforms, is changing how healthcare services are consumed.
- Health insurance penetration: Increasing insurance coverage is contributing to higher healthcare spending and improved access to services.
- Ageing population: A growing elderly population is expected to drive demand for chronic disease management, geriatric care, and long-term healthcare services.
- Medical devices manufacturing: India is positioning itself as a key manufacturing hub for medical devices, supported by production linked incentive schemes and policies promoting domestic production.
Conclusion
India’s healthcare sector is a critical and fast-growing component of the economy. From hospitals and pharmaceuticals to digital health and medical tourism, the industry offers wide-ranging opportunities for investors, entrepreneurs, and healthcare professionals. Its growth is supported by favourable demographics, rising income levels, increasing health awareness, digital adoption, and strong government backing.
For those planning to enter or expand within this sector, whether by setting up a clinic, diagnostic centre, pharmacy, or health tech venture, a Bajaj Finserv Business Loan can provide the required financial support. It is advisable to check your business loan eligibility and use a business loan EMI calculator to plan repayments effectively before applying.
